CAESAREA, Israel – April 2, 2013 – Mazor Robotics Ltd. (TASE: MZOR), the developer of
Renaissance™, an innovative surgical guidance system and its complementary products, today
announced that on March 28, 2013, it entered into an agreement for the acquisition of four
Renaissance systems by a major U.S. hospital corporation. The systems were installed in acute-
care facilities owned by the corporation in four separate U.S. markets.
“This agreement marks a significant, strategic achievement for Mazor,” said Ori Hadomi, Chief
Executive Officer of Mazor Robotics. “These first four installations will serve as the platform for
Renaissance within four of our customer’s markets, and we look forward to seeing their patients
and staff benefiting from the clinical value of our technology”.
Renaissance, Mazor Robotics’ state-of-the-art surgical guidance system for spine procedures, is
transforming spine surgery from freehand operations to highly-accurate, planned procedures,
with less intra-operative radiation – even for minimally invasive surgery, scoliosis, and other
complex spinal reconstructive surgeries.
The agreement announced today brings the total number of Renaissance installations in clinical
institutions in the USA to 26, and globally to 48.
About Mazor
Mazor Robotics (TASE:MZOR) is dedicated to the development and marketing of innovative
surgical robots and complementary products that provide a safer surgical environment for
patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is
a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an
accurate and secure manner. Mazor Robotics systems have been successfully used in the
placement of over 35,000 implants in the United States, Asia, and Europe. Numerous peer-
reviewed publications and presentations at leading scientific conferences have validated the
accuracy, usability, and clinical advantages of Mazor Robotics technology. For more
information, please visit www.mazorrobotics.com.
U.S. Contacts:
Investors
Aimee Gordon/Robert Jones
EVC Group
646-445-4800
agordon@evcgroup.com / bjones@evcgroup.com
Media
Amy Phillips
EVC Group
412-327-9499
aphillips@evcgroup.com